EARLY INFLIXIMAB TROUGH LEVELS PREDICT LATE EFFICACY OF INFLIXIMAB IN A RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACTIVE CROHN'S DISEASE COMPARING CT-P13 AND INNOVATOR INFLIXIMAB

Jae Hee Cheon  1     Kang-Moon Lee  2     Young-Ho Kim  3     Byong Duk Ye  4     Changsoo Eun  5     Sung Young Lee  6     Seul Gi Lee     Joon Ho Lee     Houng Kim     Pamela Selema     Raymond Cheung     Stefan Schreiber    
1 Yonsei University College of Medicine,Seoul,Korea (Republic of)
2 St. Vincent Hospital, The Catholic University of Korea,Suwon,Korea (Republic of)
3 Samsung Medical Center,Seoul,Korea (Republic of)
4 University of Ulsan College of Medicine,Seoul,Korea (Republic of)
5 Hanyang University Guri hospital,Gyeonggi-do,Korea (Republic of)
6 Celltr

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing